ACST Acasti Pharma, Inc. gains 41% Aug 5, 2019

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of various cardiometabolic disorders primarily abnormalities in blood lipids. The company offers Onemia, a medical food product for the dietary management of omega-3 phospholipids deficiency, and related abnormal lipid profiles and cardiometabolic disorders. It also develops CaPre, a prescription drug candidate for the prevention and treatment of cardiometabolic disorders, such as hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.http://www.priceseries.com/trade/ACST-Acasti-Pharma-Inc-stock-gains-41-percent-a-Trade-Record-by-priceSeries-2019071820190805.html